Patients taking tofacitinib (Xeljanz) in the drug's late-stage and post-marketing studies were more likely than those on ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

European Commission President Ursula von der Leyen lost a court fight against attempts to force her to disclose secret text ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

The EU’s general court has dismissed the European Commission’s refusal to disclose text messages its president Ursula von der ...

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...

The EU Court found the head of the European Commission, Ursula von der Leyen, responsible for concealing information about ...

European Court of Justice found that the Commission failed to explain why text messages with Pfizer should be kept from the ...

Ruling expected to have far-reaching implications for transparency, accountability in EU institutions - Anadolu Ajansı ...

The European Commission did not provide credible reasons for rejecting a New York Times request to hand over text messages ...

Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...